BridgePort Financial Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$861K Buy
14,943
+1,396
+10% +$80.2K 0.22% 91
2026
Q1
$822K Sell
13,547
-2,474
-15% -$144K 0.23% 85
2025
Q4
$864K Buy
16,021
+11,143
+228% +$536K 0.23% 83
2025
Q3
$220K Buy
+4,878
New +$228K 0.06% 219
2025
Q2
Sell
-3,317
Closed -$202K 199
2025
Q1
$202K Buy
+3,317
New +$193K 0.09% 156

Other funds holding BMY

BridgePort Financial Solutions's BMY Position: Q2 2026 in Review

BridgePort Financial Solutions increased its Bristol-Myers Squibb (BMY) stake by 10% in Q2 2026, buying an estimated $80.2K and bringing the position to 14,943 shares worth $861K. The position accounts for 0.22% of the portfolio, ranked #91.

BridgePort Financial Solutions first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $864K in Q4 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • BridgePort Financial Solutions held 14,943 shares of Bristol-Myers Squibb worth $861K as of Q2 2026.
  • BridgePort Financial Solutions bought 1,396 Bristol-Myers Squibb shares in Q2 2026, an estimated $80.2K.
  • Bristol-Myers Squibb made up 0.22% of BridgePort Financial Solutions's portfolio in Q2 2026, its #91 holding.
  • BridgePort Financial Solutions first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • BridgePort Financial Solutions's Bristol-Myers Squibb position peaked at $864K in Q4 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on BridgePort Financial Solutions's 13F filing for Q2 2026, filed 24 Jul 2026.